103 related articles for article (PubMed ID: 20231035)
1. Sorting out drug-eluting stents.
Webster MW; Ormiston JA
Lancet; 2010 Mar; 375(9720):1060-2. PubMed ID: 20231035
[No Abstract] [Full Text] [Related]
2. Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study.
Pareek M; Madsen M; Warnakula Olesen KK; Okkels Jensen L; Høj Christiansen E; Dalby Kristensen S; Flensted Lassen J; Thuesen L; Bøtker HE; Maeng M
EuroIntervention; 2019 Dec; 15(11):e1022-e1024. PubMed ID: 31422923
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of zotarolimus-eluting stents compared with sirolimus-eluting stents in patients undergoing percutaneous coronary interventions--a meta-analysis of randomized controlled trials.
Fan J; Du H; Yin Y; Ling Z; Wu J; Xiao P; Zrenner B
Int J Cardiol; 2013 Sep; 167(5):2126-33. PubMed ID: 22703941
[TBL] [Abstract][Full Text] [Related]
4. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
5. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
Nakazawa G; Ladich E; Virmani R
Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
Rasmussen K; Maeng M; Kaltoft A; Thayssen P; Kelbaek H; Tilsted HH; Abildgaard U; Christiansen EH; Engstrøm T; Krusell LR; Ravkilde J; Hansen PR; Hansen KN; Abildstrøm SZ; Aarøe J; Jensen JS; Kristensen SD; Bøtker HE; Madsen M; Johnsen SP; Jensen LO; Sørensen HT; Thuesen L; Lassen JF;
Lancet; 2010 Mar; 375(9720):1090-9. PubMed ID: 20231034
[TBL] [Abstract][Full Text] [Related]
7. Differential clinical outcomes after 1 year vs. 5 years in the SORTOUT III randomized comparison of zotarolimus- and sirolimus-eluting coronary stents.
Maeng M
Eur Heart J; 2014 Sep; 35(35):2340-1. PubMed ID: 25349884
[No Abstract] [Full Text] [Related]
8. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial.
Moreno R; García E; Teles R; Rumoroso JR; Cyrne Carvalho H; Goicolea FJ; Moreu J; Mauri J; Sabaté M; Mainar V; Patricio L; Valdés M; Fernández Vázquez F; Sánchez-Recalde A; Galeote G; Jimenez-Valero S; Almeida M; Lopez de Sa E; Calvo L; Plaza I; Lopez-Sendón JL; Martín JL;
Circ Cardiovasc Interv; 2013 Feb; 6(1):21-8. PubMed ID: 23403384
[TBL] [Abstract][Full Text] [Related]
10. Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.
Zhang F; Dong L; Qian J; Ge J
Ann Med; 2011 Feb; 43(1):75-9. PubMed ID: 21171912
[TBL] [Abstract][Full Text] [Related]
11. The process of bringing new drug-eluting stents to market will they see the light of day?
Holmes DR; Patel M
JACC Cardiovasc Interv; 2008 Oct; 1(5):533-4. PubMed ID: 19463355
[No Abstract] [Full Text] [Related]
12. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
[TBL] [Abstract][Full Text] [Related]
13. Everolimus versus sirolimus-eluting stents for the treatment of sirolimus-eluting stent restenosis.
Yan RQ; Gao LJ; Chen JL
Int J Cardiol; 2013 May; 165(3):568-9. PubMed ID: 23040998
[No Abstract] [Full Text] [Related]
14. Current status of the Xience V® everolimus-eluting coronary stent system.
Claessen BE; Caixeta A; Henriques JP; Piek JJ
Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1363-74. PubMed ID: 20936921
[TBL] [Abstract][Full Text] [Related]
15. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
Harjai KJ; Kondareddy S; Pinkosky B; Harjai N; Orshaw P; Boura J
J Interv Cardiol; 2013 Apr; 26(2):153-62. PubMed ID: 23363439
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents are safe.
Garg S; Serruys P
Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
[No Abstract] [Full Text] [Related]
17. Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
Park DW; Kim YH; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Seong IW; Lee JH; Tahk SJ; Jeong MH; Jang Y; Cheong SS; Yang JY; Lim DS; Seung KB; Chae JK; Hur SH; Lee SG; Yoon J; Lee NH; Choi YJ; Kim HS; Kim KS; Kim HS; Hong TJ; Park HS; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(15):1187-95. PubMed ID: 20883925
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents: effective and safe for every patient and every lesion?
Zeymer U; Zahn R
Eur Heart J; 2007 Nov; 28(21):2559-60. PubMed ID: 17938127
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.
Juwana YB; Rasoul S; Ottervanger JP; Suryapranata H
J Invasive Cardiol; 2010 Jul; 22(7):312-6. PubMed ID: 20603502
[TBL] [Abstract][Full Text] [Related]
20. Inflammation inhibitory effects of sirolimus and paclitaxel-eluting stents on interleukin-1β-induced coronary artery in-stent restenosis in pigs.
Zhou XC; Huang RC; Zhang B; Yin D; Liang B; Wang SP; Guan QG; Sun XZ; Miao ZL; He XZ; Han FT; Cheng Y; Zhang L; Zeng DY
Chin Med J (Engl); 2010 Sep; 123(17):2405-9. PubMed ID: 21034557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
